MedTrace Logo

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

NCT05274880 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-11-30

No results posted yet for this study

Summary

Study to evaluate the food effect on pharmacokinetic profiles and safety of CKD-393 in healthy volunteers

Conditions

  • Type II Diabetes Mellitus

Interventions

DRUG

CKD-393

PO, QD

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Hyewon Chung, M.D., Ph.D. · Korea University Guro Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
54 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-21
Primary Completion
2022-07-15
Completion
2022-07-26

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05274880 on ClinicalTrials.gov